Supernus Pharmaceuticals ...

NASDAQ: SUPN · Real-Time Price · USD
43.33
1.16 (2.75%)
At close: Aug 15, 2025, 12:01 PM

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals reported an annual revenue of $661.82M, reflecting a 8.94% growth. For the quarter ending June 30, 2025, Supernus Pharmaceuticals generated $165.45M in revenue.
Revenue (ttm)
661.82M
Revenue Growth
8.94%
Price / Sales Ratio
3.01
Revenue / Employee
981.92K
Employees
674
Market Cap
2.43B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.